By Priya Kalia, SciTribe and Miranda Weston-Smith, BioBeat
London, June 5th 2025 – Coulter Partners, the global expert building leadership teams for Health, Science and Technology innovation businesses, successfully completed a search assignment for Melt&Marble and is pleased to announce the placement of Tue Hodal as its first Chief Technology Officer (CTO).
Your role
ROLE OVERVIEW
A leading company in the gene therapy sector is seeking a Principal Scientist – Bioassay Development for a 12-month contract based in London, UK. This role offers the chance to work with a pioneering organisation focused on advancing gene therapies for chronic renal diseases.
As the Principal Scientist – Bioassay Development, you will play a critical role in the development and application of in vitro potency assays for gene therapy products, particularly those involving AAV.
We are currently hiring for an innovative biotechnology company at the forefront of scientific discovery and technological integration is seeking a dynamic Vice President of R&D Services in the South East of the UK. Specialising in vector-borne disease control, odour-based biomarker detection, and smart environmental sensing, the organisation is redefining how applied research powers real-world solutions in public health and pest management. The company combines deep scientific expertise with cutting-edge data platforms to drive commercial product development globally.
Read June eNews here
Featuring:
AI is becoming an increasingly powerful tool in business, from using Copilot to making everyday admin more efficient, to bespoke platforms to integrate in-house software systems. Many SMEs are considering its adoption to help them to streamline processes, interrogate data, even to discover new products and services. But how do you start on this journey to AI adoption in your organisation, and what are you exposing your business to?
We have three speakers to help you.
High levels of self-awareness and a growth mindset are key to understanding yourself and others. But while most of us believe ourselves to be self-aware research has suggested that in fact only 10-15% of us are truly self-aware.
Self-awareness involves being aware of different aspects of ourselves, including our characteristics, behaviours and feelings. By gaining a deeper understanding of how they are perceived by others makes room for growth and change which increases personal effectiveness.
The Fisher Scientific channel is proud to have been re-awarded as a Preferred Supplier to its members. Under this renewed and expanded agreement, One Nucleus Gold members can benefit from significant cost savings through the established purchasing framework.
by Tony Jones, CEO, One Nucleus
